| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/04/2008 | EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 06/04/2008 | EP1193250B1 Phenyl sulfamate derivatives |
| 06/04/2008 | EP1189614B1 Solid preparations containing paroxetine |
| 06/04/2008 | CN101193914A Antibodies directed against amyloid-beta peptide and methods using same |
| 06/04/2008 | CN101193898A Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-one derivatives |
| 06/04/2008 | CN101193897A Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
| 06/04/2008 | CN101193892A Macrocyclic heterocyclic aspartyl protease inhibitors |
| 06/04/2008 | CN101193859A The preparation and use of compounds as protease inhibitors |
| 06/04/2008 | CN101193858A Inhibitors of neurotrypsin and determination thereof |
| 06/04/2008 | CN101193640A Pharmaceutical compositions of a neuroactive steroid and uses thereof |
| 06/04/2008 | CN101193632A Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 06/04/2008 | CN101193628A Pharmaceutical formulations of amyloid inhibiting compounds |
| 06/04/2008 | CN101193625A Sugar-coated tablet |
| 06/04/2008 | CN101190914A 16-site substituted double functional group huperzine B derivative, preparation method and use thereof |
| 06/04/2008 | CN101190330A Application of cholinesterase in antagonistic tachykinin medicine |
| 06/04/2008 | CN101190327A í«Kanlijiaobuyeí» a kind of traditional Chinese medicinal oral liquid |
| 06/04/2008 | CN101190322A Traditional Chinese medicine for treating zoster post herpetic neuralgia |
| 06/04/2008 | CN101190315A Traditional Chinese medicine composition for treating melancholia and preparation method thereof |
| 06/04/2008 | CN101190312A Drug rehabilitation proprietary Chinese medicine |
| 06/04/2008 | CN101190295A Heat-clearing, detoxication and lag-dispelling Chinese herbal medicine health care cold tea and its preparation method |
| 06/04/2008 | CN101190289A Traditional Chinese medicine for treating combined hemorrhoid postoperative edema pain |
| 06/04/2008 | CN101190273A Traditional Chinese medicine emplastrum for repairing acute and chronic injury |
| 06/04/2008 | CN101190271A A set of medicinal compositions for treating melancholia and preparation method |
| 06/04/2008 | CN101190269A A set of medicinal compositions for improving cognitive impairment and treating senile dementia |
| 06/04/2008 | CN101190268A Compound medicine for treating cervical spondylosis |
| 06/04/2008 | CN101190267A Medicinal composition for treating cervical vertebra disease |
| 06/04/2008 | CN101190246A Method for extracting active component of acanthopanax senticosus for treating parkinson's disease |
| 06/04/2008 | CN101190225A Phenobarbitone chewable tablets for dog or cat |
| 06/04/2008 | CN101190218A New use of tizanidine and its derivatives |
| 06/04/2008 | CN101190208A Medicinal preparations containing duloxetine hydrochloride and preparation method thereof |
| 06/04/2008 | CN101190196A Diazepam chewable tablets for dog or cat |
| 06/04/2008 | CN101190176A Huperzine A derivative xipulin preparations |
| 06/04/2008 | CN101190172A Toothpaste for giving-up smoking containing bioactivity factor and its manufacturing method |
| 06/04/2008 | CN101190025A Food for sobering-up, promoting digestion and protecting liver |
| 06/04/2008 | CN100391959C Pyrimidine-5-(1H)-ketone derivative |
| 06/04/2008 | CN100391952C Citalopram salt preparing and purifying process |
| 06/04/2008 | CN100391935C Cyclopentyl derivates |
| 06/04/2008 | CN100391933C Substituted 1-aminobutan-3-01 derivatives |
| 06/04/2008 | CN100391533C Wood louse analgesia peptide, preparation method and application |
| 06/04/2008 | CN100391519C Cranial nerves rehabilitation medicine and its preparation method |
| 06/04/2008 | CN100391506C Medicine for treating dementia and preparing method thereof |
| 06/04/2008 | CN100391484C Medicine for treating cardio-cerebrovascular disease |
| 06/04/2008 | CN100391465C Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 06/04/2008 | CN100391458C Preparation method of ziprasidone or its salt inclusion |
| 06/04/2008 | CN100391448C Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381746 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| 06/03/2008 | US7381745 Central nervous system disorders; psychological disorders |
| 06/03/2008 | US7381741 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 06/03/2008 | US7381735 Ultrashort-acting opioids for transdermal application |
| 06/03/2008 | US7381733 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 06/03/2008 | US7381726 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 06/03/2008 | US7381725 Pyridazine derivatives as ligands for GABA receptors |
| 06/03/2008 | US7381724 6(5-chloro-2-pyridyl-)-5-[4-methyl-1-piperazinyl]carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine for tranquilizers or hypnotics |
| 06/03/2008 | US7381723 Antiserotonine agents; stroke, brain disorders;trauma; Alzheimer's disease; neurodegenerative disease; schizophrenia; psychological disorders; anxiolytic agents; controlling stresses; eating disorders; sleep disorders; sexual disorders |
| 06/03/2008 | US7381702 Methods of treating diabetes mellitus |
| 06/03/2008 | US7381700 with botulinum toxin |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | US7381429 Hormone replacemnent therapy; menopause, osteoporosis, cardiovascular disorders; stroke; sexual disorders |
| 06/03/2008 | US7381424 Hydrostatic delivery system for controlled delivery of agent |
| 06/03/2008 | US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development |
| 06/03/2008 | CA2401711C Cyclic amide derivatives |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2368186C Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 06/03/2008 | CA2339934C Medicine for multiple sclerosis |
| 06/03/2008 | CA2335560C New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 06/03/2008 | CA2326356C Oral liquid antidepressant solution |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2279846C Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 06/03/2008 | CA2256015C Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic |
| 06/03/2008 | CA2122596C Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/29/2008 | WO2008064296A1 Method of treating neurological disorders with carbonic anhydrase inhibitors |
| 05/29/2008 | WO2008063847A2 Method for treating autism |
| 05/29/2008 | WO2008063842A2 Methods of treating neuropathic pain with agonists of ppar-gamma |
| 05/29/2008 | WO2008063625A2 Pyridine compounds and methods of their use |
| 05/29/2008 | WO2008063128A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/29/2008 | WO2008063114A1 Amino- imidazolones and their use as medicament for treating cognitive impairment alzheimer disease, neurodegeneration and dementia |
| 05/29/2008 | WO2008063099A1 Agent and method for preventing and treating intoxication by alcohol-containing liquids and alcohol substitutes |
| 05/29/2008 | WO2008062905A2 Heteromonocyclic compound and use thereof |
| 05/29/2008 | WO2008062424A2 Substituted 4,5-dihydro-1h-pyrazole derivatives as cannabinoid modulators |
| 05/29/2008 | WO2008062232A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | WO2008062201A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | WO2008062044A1 2-hydroxy-1,3-diaminopropane derivatives |
| 05/29/2008 | WO2008062040A1 Anticonvulsive pharmaceutical compositions |
| 05/29/2008 | WO2008061955A1 Benzoisoindole derivatives and their use as ep4 receptor agonists |
| 05/29/2008 | WO2008061795A2 N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| 05/29/2008 | WO2008061781A1 Thiadiazole derivatives for the treatment of neuro-degenerative diseases |
| 05/29/2008 | WO2008061757A1 Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses |
| 05/29/2008 | WO2008061756A1 Dietary and pharmaceutical compositions comprising a sage extract containing a mixture of tricyclic diterpenes and their derivatives and their uses |
| 05/29/2008 | WO2008061754A1 Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression |
| 05/29/2008 | WO2008061688A1 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders |
| 05/29/2008 | WO2008061373A1 Combination treatments for alzheimer's disease and similar diseases |
| 05/29/2008 | WO2008061329A2 PHα1B TOXIN, CDNA OF PHα1 B TOXIN GENE, PHARMACEUTICAL COMPOSITIONS CONTAINING PHα1B TOXIN, PROCESSES FOR THEIR OBTENTION AND PRODUCT |
| 05/29/2008 | WO2008061306A1 Metal delivery agents and therapeutic uses of the same |
| 05/29/2008 | WO2008021532A3 Treatment of inflammatory diseases |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2007138301A3 Novel formulation |
| 05/29/2008 | WO2007118819A3 Novel crystalline compounds |
| 05/29/2008 | WO2007111983A3 New therapeutic combinations for the treatment or prevention of psychotic disorders |
| 05/29/2008 | WO2007072150A3 Piperidine derivatives |